Stock AHCO ADAPTHEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AdaptHealth Corp.

Equities

AHCO

US00653Q1022

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
9.85 USD +0.10% Intraday chart for AdaptHealth Corp. +7.18% +35.12%
May. 07 AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast MT
May. 07 Transcript : AdaptHealth Corp., Q1 2024 Earnings Call, May 07, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 442.5 2,681 3,234 2,590 984.1 1,273 - -
Enterprise Value (EV) 1 782.2 3,366 5,303 4,732 3,055 3,275 3,292 3,322
P/E ratio -16.6 x -30.5 x 36.5 x 58.2 x -1.44 x 16.6 x 10.8 x 8.57 x
Yield - - - - - - - -
Capitalization / Revenue 0.84 x 2.54 x 1.32 x 0.87 x 0.31 x 0.38 x 0.36 x 0.34 x
EV / Revenue 1.48 x 3.19 x 2.16 x 1.59 x 0.95 x 0.99 x 0.94 x 0.88 x
EV / EBITDA 6.36 x 16.4 x 9.37 x 7.97 x 4.55 x 4.78 x 4.5 x 4.23 x
EV / FCF 20 x 21.6 x 52.8 x -270 x 21.3 x 20 x 22.2 x 19.7 x
FCF Yield 5% 4.63% 1.89% -0.37% 4.69% 5.01% 4.49% 5.08%
Price to Book -11.8 x 9.79 x 1.59 x 1.19 x 0.67 x 0.88 x 0.82 x 0.76 x
Nbr of stocks (in thousands) 40,296 71,391 132,215 134,732 134,991 129,267 - -
Reference price 2 10.98 37.56 24.46 19.22 7.290 9.850 9.850 9.850
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 529.6 1,056 2,455 2,971 3,200 3,315 3,517 3,794
EBITDA 1 123 205.6 565.9 593.8 670.8 685.4 731.1 786.3
EBIT 1 60.45 123.2 307.9 242.6 288 289.9 324.2 384.5
Operating Margin 11.41% 11.66% 12.54% 8.17% 9% 8.75% 9.22% 10.13%
Earnings before Tax (EBT) 1 -11.73 -70.67 191 97.9 -723.8 128.4 190.1 -
Net income 1 -15 -64.48 156.2 69.32 -678.9 81.01 129.9 140.9
Net margin -2.83% -6.1% 6.36% 2.33% -21.21% 2.44% 3.69% 3.71%
EPS 2 -0.6600 -1.230 0.6700 0.3300 -5.060 0.5942 0.9141 1.150
Free Cash Flow 1 39.09 155.9 100.4 -17.56 143.2 164 148 168.7
FCF margin 7.38% 14.76% 4.09% -0.59% 4.47% 4.95% 4.21% 4.45%
FCF Conversion (EBITDA) 31.77% 75.81% 17.74% - 21.35% 23.92% 20.24% 21.45%
FCF Conversion (Net income) - - 64.3% - - 202.41% 113.92% 119.7%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 702.1 706.2 727.6 756.5 780.3 744.6 793.3 804 858.2 792.5 802.6 838.2 881.7 834.9 859.9
EBITDA 1 158.1 137.6 150 160.2 146 134 171 161.2 204.6 158.5 164 169.2 192.9 159.6 183.8
EBIT 1 80.85 60.61 70.53 67.83 43.61 40.15 71.75 63.86 112.3 65.61 64.58 69.04 94.42 60.6 82
Operating Margin 11.52% 8.58% 9.69% 8.97% 5.59% 5.39% 9.04% 7.94% 13.08% 8.28% 8.05% 8.24% 10.71% 7.26% 9.54%
Earnings before Tax (EBT) 1 33.5 47.83 24.1 22.81 3.162 14.96 20.44 -487.5 -271.7 5.501 27.71 35.9 55.93 - -
Net income 1 22.94 41.75 14.03 16.12 -2.588 15.71 13.98 -454.1 -254.5 -2.134 19.68 21.82 41.45 11.92 30.52
Net margin 3.27% 5.91% 1.93% 2.13% -0.33% 2.11% 1.76% -56.47% -29.65% -0.27% 2.45% 2.6% 4.7% 1.43% 3.55%
EPS 2 0.1500 0.0800 0.0900 0.1100 -0.0200 0.1155 0.0900 -3.370 -1.910 -0.0200 0.1431 0.1619 0.3070 0.0850 0.2200
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/24/22 5/10/22 8/9/22 11/8/22 2/27/23 5/9/23 8/8/23 11/7/23 2/27/24 5/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 340 685 2,069 2,142 2,071 2,002 2,019 2,049
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.761 x 3.33 x 3.657 x 3.607 x 3.087 x 2.921 x 2.761 x 2.606 x
Free Cash Flow 1 39.1 156 100 -17.6 143 164 148 169
ROE (net income / shareholders' equity) 41.9% 34.9% 14.4% 4.54% 7.89% 7.37% 9.74% 11.3%
ROA (Net income/ Total Assets) -3.27% 5.24% 4.42% 1.83% 1.49% 2.92% 3.62% 4.49%
Assets 1 458 -1,231 3,532 3,793 -45,490 2,778 3,586 3,136
Book Value Per Share 2 -0.9300 3.840 15.40 16.10 10.90 11.20 11.90 12.90
Cash Flow per Share 2 2.680 3.730 2.280 2.690 3.580 3.640 3.930 4.090
Capex 1 21.3 39.8 203 391 337 344 359 361
Capex / Sales 4.03% 3.76% 8.28% 13.18% 10.55% 10.37% 10.21% 9.5%
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for AdaptHealth Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
9.85 USD
Average target price
11.85 USD
Spread / Average Target
+20.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ADAPTHEALTH CORP. Stock AdaptHealth Corp.
+35.12% 1.27B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.72% 182B
MEDTRONIC PLC Stock Medtronic plc
+3.96% 112B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.93% 68.58B
DEXCOM, INC. Stock DexCom, Inc.
+6.30% 51.58B
CENCORA, INC. Stock Cencora, Inc.
+8.02% 44.24B
HOYA CORPORATION Stock Hoya Corporation
+8.23% 43.65B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+26.18% 32.46B
TERUMO CORPORATION Stock Terumo Corporation
+17.05% 25.99B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.57% 25.61B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AHCO Stock
  4. Financials AdaptHealth Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW